Background: Y-Aminobutyric acid (GABA) is a central inhibitory neurotransmitter that also exists in peripheral tissues, including the lung. The GABA-agonist baclofen has been shown, in animal studies, to inhibit cough via a central mechanism, but has not been investigated in humans (to our knowledge). Study objective: To evaluate the antitussive effect of baclofen in normal human subjects. Design: Randomized, double-blind, placebo-controlled study.
Study Protocol
After undergoing baseline capsaicin cough challenge, subjects were randomly assigned, in a double-blind manner, to take oral baclofen (Zenith Laboratories; Northvale, NJ), 10 [Fig 1] ).
All subjects reported compliance with the study protocol. Four 
